<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Relmada Therapeutics, Inc.</title><link>https://investorshangout.com/Relmada-Therapeutics-Inc-RLMD-90492/</link><description><![CDATA[Relmada Therapeutics, Inc. (RLMD)]]></description><language>en-us</language><pubDate>Sun, 13 Sep 2026 22:40:01 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/Relmada-Therapeutics-Inc-RLMD-90492/" rel="self" type="application/rss+xml"/><item><title>whytestocks: $RLMD News Article - Relmada Therapeutics to Report Fourth Quarter and Full-Year 2023 Financial Resu</title><link>https://investorshangout.com/post/view?id=6677491</link><guid>https://investorshangout.com/post/view?id=6677491</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 12 Mar 2024 12:15:45 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - Relmada Therapeutics to Present New Preclinical Data on its Psilocybin Program </title><link>https://investorshangout.com/post/view?id=6630607</link><guid>https://investorshangout.com/post/view?id=6630607</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 11 Oct 2023 16:40:47 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - Relmada Therapeutics to Present Data from its REL-1017 and Psilocybin Programs </title><link>https://investorshangout.com/post/view?id=6628270</link><guid>https://investorshangout.com/post/view?id=6628270</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 06 Oct 2023 17:45:50 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claim</title><link>https://investorshangout.com/post/view?id=6593359</link><guid>https://investorshangout.com/post/view?id=6593359</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 06 Jul 2023 15:30:46 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Cla</title><link>https://investorshangout.com/post/view?id=6592357</link><guid>https://investorshangout.com/post/view?id=6592357</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 03 Jul 2023 15:00:47 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - Relmada Therapeutics Appoints Fabiana Fedeli from M&amp;G Investments to its Board </title><link>https://investorshangout.com/post/view?id=6521976</link><guid>https://investorshangout.com/post/view?id=6521976</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 12 Jan 2023 15:25:46 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - Relmada Therapeutics Appoints CNS Therapeutic Expert Cedric O&#039;Gorman MD as Chie</title><link>https://investorshangout.com/post/view?id=6520485</link><guid>https://investorshangout.com/post/view?id=6520485</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 09 Jan 2023 19:50:50 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - Relmada Therapeutics Receives FDA Fast Track Designation for REL-1017 as a Mono</title><link>https://investorshangout.com/post/view?id=6451590</link><guid>https://investorshangout.com/post/view?id=6451590</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 09 Aug 2022 23:10:57 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - Relmada Therapeutics Announces Publication of REL-1017 Preclinical Data in Fron</title><link>https://investorshangout.com/post/view?id=6393329</link><guid>https://investorshangout.com/post/view?id=6393329</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 29 Apr 2022 17:15:52 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in $172.5 Mill</title><link>https://investorshangout.com/post/view?id=6302306</link><guid>https://investorshangout.com/post/view?id=6302306</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 15 Dec 2021 16:50:49 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - Relmada Therapeutics to Present at Oppenheimer Fall Healthcare Life Sciences an</title><link>https://investorshangout.com/post/view?id=6242703</link><guid>https://investorshangout.com/post/view?id=6242703</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 17 Sep 2021 15:00:50 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - Relmada Therapeutics Announces Top-Line Results of Study Evaluating REL-1017 vs</title><link>https://investorshangout.com/post/view?id=6197772</link><guid>https://investorshangout.com/post/view?id=6197772</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 27 Jul 2021 14:10:46 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - Relmada Therapeutics to Participate in Upcoming Investor Conferences </title><link>https://investorshangout.com/post/view?id=5965106</link><guid>https://investorshangout.com/post/view?id=5965106</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 17 Nov 2020 16:40:49 GMT</pubDate></item><item><title>znewcar1: RLMD 36% v1,3M c47.18 f10M H 49.8 EOD push</title><link>https://investorshangout.com/post/view?id=5609905</link><guid>https://investorshangout.com/post/view?id=5609905</guid><description><![CDATA[znewcar1
]]></description><pubDate>Wed, 04 Dec 2019 21:24:24 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - Relmada Therapeutics Announces Proposed Public Offering of Common Stock </title><link>https://investorshangout.com/post/view?id=5608740</link><guid>https://investorshangout.com/post/view?id=5608740</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 03 Dec 2019 21:20:42 GMT</pubDate></item><item><title>znewcar1: RLMD 134% v2,2M c26.20 f9,8M H 36 S@19 then bounced around VWAP</title><link>https://investorshangout.com/post/view?id=5565607</link><guid>https://investorshangout.com/post/view?id=5565607</guid><description><![CDATA[znewcar1
]]></description><pubDate>Tue, 15 Oct 2019 20:29:22 GMT</pubDate></item><item><title>whytestocks: $RLMD News Article - Relmada Therapeutics to Present at LD Micro Invitational Conference in Los Ange</title><link>https://investorshangout.com/post/view?id=5452706</link><guid>https://investorshangout.com/post/view?id=5452706</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 03 Jun 2019 19:00:40 GMT</pubDate></item><item><title>znewcar1: 32.35% V16K c3:58 f30,266,373 Gap up and ran</title><link>https://investorshangout.com/post/view?id=5368658</link><guid>https://investorshangout.com/post/view?id=5368658</guid><description><![CDATA[znewcar1
]]></description><pubDate>Tue, 05 Mar 2019 03:05:47 GMT</pubDate></item><item><title>Griftersbro: This stock is so undervalued it&#039;s silly</title><link>https://investorshangout.com/post/view?id=4354950</link><guid>https://investorshangout.com/post/view?id=4354950</guid><description><![CDATA[Griftersbro
]]></description><pubDate>Tue, 14 Feb 2017 15:15:45 GMT</pubDate></item></channel></rss>